Multi Cancer Early Detection Market Forecast Report 2025-2033: A $4.3 Billion Market by 2033, as Market Set to Quadruple from $1 Billion Valuation in 2024
Multi Cancer Early Detection Market
Dublin, Aug. 11, 2025 (GLOBE NEWSWIRE) -- The "Multi Cancer Early Detection Market and Forecasts 2025-2033" report has been added to ResearchAndMarkets.com's offering.
The global multi cancer early detection market size was valued at USD 1 billion in 2024 and is likely to reach USD 4.3 billion by 2033, expanding at a CAGR 16.9% during the forecast period.
The multi cancer early detection market is experiencing significant growth as advancements in technology and changing healthcare paradigms evolve. Early detection of cancer can lead to improved treatment outcomes and potentially save lives, making this market increasingly important in the realm of healthcare.
One of the primary drivers of the multi cancer early detection market is the rapid advancement of diagnostic technologies. Innovations in genomics, artificial intelligence, and imaging techniques are enhancing the accuracy and efficiency of cancer detection. These cutting-edge technologies allow for the identification of multiple cancer types simultaneously, which is crucial for timely intervention.
Another key factor contributing to the market's expansion is the growing public awareness regarding the importance of early cancer detection. More individuals are prioritizing preventive healthcare measures, leading to increased screenings and tests. Health campaigns and education initiatives are empowering patients to take charge of their health, thereby stimulating demand for multi-cancer early detection solutions.
Multi Cancer Early Detection Market Synopsis
This new 2025 market report presents an in-depth assessment of the global multi cancer early detection market dynamics, opportunities, future road map, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook in the global multi-cancer early detection market. The report also provides up-to-date historical market size data for the period 2020 - 2024 and an illustrative forecast to 2033 covering key market aspects like market value, share, analysis, and trends for the global multi cancer early detection market.
The report provides a detailed analysis of the current industry situation and market requirements, highlighting facts about the market size, market share, revenue for global multi cancer early detection market segments, and a vivid forecast to 2033.
It also provides a comprehensive analysis of the pricing landscape, policies and regulation, and reimbursement pattern by countries and regions. The report also offers analysis and information according to categories such as market segments, application, technology, geographies, companies and competitive landscape. The report also provides a detailed description of the porter's five forces analysis, PESTEL analysis, SWOT analysis, funding, merger and acquisitions, pipeline, growth drivers and challenges of the global multi cancer early detection market.
The report concludes with the profiles of major market players in the global multi cancer early detection market. The key market players are evaluated on various parameters such as company overview, product landscape, recent developments in multi cancer early detection, funding & M&A, strategic outlook, challenges and risks of the global multi cancer early detection market.
Multi Cancer Early Detection Market by Key Players
GRAIL, Inc. (an Illumina Company)
Guardant Health
Exact Sciences Corporation
Illumina, Inc.
Freenome Holdings, Inc.
Burning Rock Biotech Limited
Foundation Medicine, Inc.
AnchorDx
Beijing Lyman Juntai International Medical Technology Development Co.
Genecast
Singlera Genomics Inc
Thrive Earlier Detection (acquired by Exact Sciences Corporation)
Key Features of the Report
The global multi cancer early detection market provides granular level information about the market size, regional market share, historic market (2020-2024), and forecast (2025-2033).
Annualized revenues and country level analysis for each market segment.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Detailed analysis of geographical landscape with country level analysis of major regions.
The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and key strategies.
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.
The report analyses the impact of the socio-political environment through SWOT analysis and competition through porter's five force analysis and PESTEL analysis
Through study of the key business strategies and recommendations on future market approach.
Comprehensive analysis of the competitive structure of the market.
Demand side and supply side analysis of the market.
Key Questions the Report Addresses
How big is the global multi cancer early detection market?
What is the current multi cancer early detection market size?
What is the major driving factor for the multi cancer early detection market?
Which factor is restraining the growth of the multi cancer early detection market?
Who are the key players in the multi cancer early detection market?
Which region has the biggest share in the multi cancer early detection market?
Which is the fastest growing country in the multi cancer early detection market?
Key Attributes:
Report Attribute
Details
No. of Pages
150
Forecast Period
2024 - 2033
Estimated Market Value (USD) in 2024
$1 Billion
Forecasted Market Value (USD) by 2033
$4.3 Billion
Compound Annual Growth Rate
16.9%
Regions Covered
Global
Key Topics Covered:
1. Market Definition
2. Research and Methodology
3. Executive Summary
4. Global Multi Cancer Early Detection - Market Dynamics4.1 Growth Drivers4.2 Challengers4.3 Funding and Merger & Acquisitions
5. Global Multi Cancer Early Detection Market - Industry Analysis5.1 SWOT Analysis5.2 Porter's Analysis
6. Global Multi Cancer Early Detection (MCED) Market & Forecast
7. Global Multi Cancer Early Detection (MCED) Market Share & Forecast7.1 By Types7.2 By End Use7.3 By Region7.4 By Country
8. By Types - Global Multi Cancer Early Detection (MCED) Market & Forecast8.1 Gene Panel, IDT & Others8.2 Liquid Biopsy
9. By End Use - Global Multi Cancer Early Detection (MCED) Market & Forecast9.1 Hospitals9.2 Diagnostic Laboratories9.3 Others
10. By Region - Global Multi Cancer Early Detection (MCED) Market & Forecast10.1 North America10.2 Europe10.3 Asia Pacific10.4 Latin America10.5 Middle East & Africa
11. By Country - Global Multi Cancer Early Detection (MCED) Market & Forecast
12. Global Multi Cancer Early Detection Market - Key Players Profiles
GRAIL, Inc. (an Illumina Company)
Guardant Health
Exact Sciences Corporation
Illumina, Inc.
Freenome Holdings, Inc.
Burning Rock Biotech Limited
FOUNDATION MEDICINE, INC.
AnchorDx
Beijing Lyman Juntai International Medical Technology Development Co.
GENECAST
Singlera Genomics Inc.
Thrive Earlier Detection (acquired by Exact Sciences Corporation)
For more information about this report visit https://www.researchandmarkets.com/r/ovdma8
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
Multi Cancer Early Detection Market
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
Day traders scorched Wall Street pros with a hot summer. But September could chill their vibe.
Day traders outperformed pros this summer but face a potential September pullback. Retail traders drove stock gains, but historical trends suggest a volatile September. Hedge funds struggled with 'garbage' stock rallies, but might be better positioned for the fall. Day traders have had a blockbuster summer, outpacing professional money managers and leaving some hedge funds bruised. But that dominance may be short-lived. If historical trends hold, a seasonal pullback in retail activity could collide with a surge in volatility this September, threatening to derail the rally they helped drive. While nothing has topped the meme-stock craze of 2021, retail traders have been enjoying a busy — and lucrative — summer. Citadel Securities, which handles more than a third of the US retail equity trades, said in a client note last week that Main Street has remained consistently bullish over the last three months. Retail has bought up stocks in 14 of the last 16 weeks since April and options buying has been bullish for 14 consecutive weeks, according to Scott Rubner, head of equity and equity derivatives strategy at the Miami-based trading giant. Their optimism has been rewarded. The S&P 500 has gained 8% since June and nearly 30% since its low in early April. The Nasdaq has fared even better. It's not just AI-adjacent companies driving the gains, either — day traders have led a rally in so-called "garbage" stocks with questionable business prospects, such as brick-and-mortar retailers Kohl's, American Eagle, and Krispy Kreme. Many professional money managers, by contrast, have missed the boat on the stock rally, taking a cautious approach amid signs of economic threats. Citadel Securities' institutional clients have been bearish 8 of the past 12 weeks, Rubner said. Some hedge funds have been punished. The surge in junk stocks has confounded models at equity quant funds, contributing to a weekslong bloodletting, Business Insider previously reported. Many long-short equity hedge funds have navigated the market well, but those with more pessimistic outlooks have faltered. One hedge fund exec told BI that brick-and-mortar retailers with significant tariff exposure nonetheless trading higher than before tariffs were announced — especially with recession indicators blinking — "doesn't make sense to us fundamentally." David Einhorn's Greenlight Capital — which in the first quarter believed a recession and bear market were in the offing — lost 3.8% in the second quarter, trimming its year-to-date gain to just 4.1%, according to an August 7 investor letter seen by Business Insider. "While we anticipated the possibility of 'rip your face off' rallies, we certainly didn't expect the market to reach new all-time highs so quickly," the letter reads. "We still believe that the economy is slowing and could very well be headed into a recession. The market obviously disagrees." The diverging views among professional and amateur investors hit a new level in August after an unexpectedly poor jobs report and signs that inflation is ticking back up. Stocks fell that Friday, August 1 — but quickly rallied the following week. "The US stock market does not always reflect the broader economy," Rubner wrote, noting that competition is increasing for "dip alpha" — that is, investors are quick to buy stocks after a market dip, betting that stocks just went on sale and will rise in short order. A critical pivot point As we head toward fall, the stage is set for a reversal of fortune. If August is a lazy day at the beach for the stock market, September is like an icy cold plunge. While stocks generally rise in August — "consistent with the number of vacations, pool parties, and the general unwillingness to put on a new short during August," Rubner says — September is the worst month for performance, according to data going back to 1928. It's also historically more volatile. This persistent seasonal quirk is in part a byproduct of the summer holiday — traders return from vacation and rebalance their books as they gear up for an end-of-year push, cutting positions to make room for new ones. Many mutual funds similarly rebalance in September, dumping losing positions and adding to the downward pressure. September is also the nadir for retail traders. Retail participation traditionally thins as fall arrives, decelerating in August before hitting September, the lowest activity month of the year. Whether they're reacting to September's historic weakness or a factor in driving it, if Main Street money pulls back, that may take some wind out of the market's sails. And both macroeconomic and fundamental weaknesses that the market previously shrugged off could loom large. Einhorn's Greenlight says outside of companies benefiting from AI and the data center boom, "it is hard to find other areas that are doing well." The fund expects "the increased bite from tariffs to show up on shelves and in the data by September or October." Additionally, Rubner expects systematic, factor-driven strategies to reach full exposure by the end of August, "increasing vulnerability to downside shocks." In dissecting the rally in junk stocks and corresponding quant hedge fund losses, former AQR financial market research head Aaron Brown said in a column for Bloomberg that the likeliest resolution "is that the garbage rally runs out of steam and the junk stock prices sag back." He continued: "The nimble traders who took daily profits keep their winnings, the quant funds make back their losses, and the losers are less nimble day traders and medium or long-term investors who overpaid for junk." Overall retail participation in the US stock market has steadily increased, but a showdown is looming next month. Seasonal headwinds could test the resilience of the day traders and end their summer winning streak over the professional money managers. Read the original article on Business Insider Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
31 minutes ago
- Yahoo
Driving theory test to include CPR first aid questions
People sitting their driving theory test will soon need to swot up on life-saving cardiopulmonary resuscitation (CPR) skills, the UK's Driver and Vehicle Standards Agency (DVSA) has decided. All road users are being encouraged to learn the basics and know how to use a defibrillator in an emergency. It's hoped the questions, which will be added to the car and motorcycle theory test in early 2026, could prevent avoidable deaths. Drivers are often first on the scene when someone suffers a cardiac arrest, says the DVSA. Adding the information into the official learning materials means that the 2.4 million learner drivers who take their theory test each year will have a better understanding of the skills to use in an emergency, it says. Learning materials have already been updated with the new content, including questions such as "Who can use a public access defibrillator?" - the answer being "everyone". A defibrillator gives a jolt of energy to the heart, which can help get it beating normally. The devices are designed to be user-friendly, with clear instructions. If CPR is given and a defibrillator used within the first minutes of collapse, survival rates could be as high as 70%, evidence suggests. Without it, fewer than one in 10 survive. If someone is unconscious and not breathing normally, call 999 and start CPR straight away. This can be "hands-only" CPR to deliver timely chest compressions to get blood pumping. One of the new theory test questions is about the correct depth to push down. To carry out a chest compression, the NHS advises: kneel next to the person and place the heel of your hand on the breastbone at the centre of their chest. Place the palm of your other hand on top of the hand that's on their chest and interlock your fingers position yourself so your shoulders are directly above your hands using your body weight (not just your arms), press straight down by 5 to 6cm (2 to 2.5 inches) on their chest keeping your hands on their chest, release the compression and allow their chest to return to its original position repeat these compressions at a rate of 100 to 120 times a minute until an ambulance arrives or for as long as you can James Cant, chief executive of Resuscitation Council UK, said: "We're delighted to be working with the DVSA and other partners to introduce CPR and defibrillator awareness into the driving theory test. "By embedding these life-saving skills into such a widely taken assessment, we can help ensure that more people, from all communities, gain the knowledge and confidence to act during a cardiac arrest." 10,000 extra driving tests a month to clear backlog
Bloomberg
33 minutes ago
- Bloomberg
A New Approach to Sustainable Investing
Bill Davis, Portfolio Manager for the Hennessy Sustainable ETF, breaks down some of his top stock picks, which he says offer a unique hedge to a market riding high on the AI trade. Bill speaks with Carol Massar and David Gura on Bloomberg Businessweek Daily. (Source: Bloomberg)
